Triple-negative breast cancer (TNBC) rep­resents a diverse group of cancers that are characterized by lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) amplification [1,2,3]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.